We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Why Can’t mTOR Inhibitors Kill Cancer?

News   Oct 06, 2017 | Original story from UT Health San Antonio

 
Why Can’t mTOR Inhibitors Kill Cancer?

Mitochondrial elongation, induced by mTOR-inhibiting drugs, contributes to cell survival. Credit: Facility for Electron Microscopy Research/McGill University Department of Anatomy and Cell Biology.

 
 
 

RELATED ARTICLES

Alzheimer's Trafficking Defect Corrected in Rodents

News

UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.

READ MORE

Immune System Kept in Check by Protein Police

News

Researchers learn how a key transcription factor helps regulate the immune system and could be critical to understanding autoimmune disease and cancer immunosuppression.

READ MORE

Super-resolution Microscopy at its Best

News

Does expansion microscopy deliver true-to-life images of cell structures? A new publication shows for the first time that the method actually works reliably.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE